Gene · 79679
Papers2,409
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,281 to 1,300 of 2,409
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune checkpoint: The novel target for antitumor therapy. | Genes Dis | 2021 | 33569511 | PubTator, text mining | PubMed |
| Development and validation of a nomogram for predicting survival of pulmonary invasive mucinous adenocarcinoma based on surveillance, epidemiology, and end results (SEER) database. | BMC Cancer | 2021 | 33568091 | PubTator, text mining | PubMed |
| Hypoxia Molecular Characterization in Hepatocellular Carcinoma Identifies One Risk Signature and Two Nomograms for Clinical Management. | J Oncol | 2021 | 33552157 | PubTator, text mining | PubMed |
| Sequencing Analysis of mRNA Profile in Endothelial Cells in Response to ox-LDL. | Biochem Genet | 2021 | 33528699 | PubTator, text mining | PubMed |
| B7-H3×4-1BB bispecific antibody augments antitumor immunity by enhancing terminally differentiated CD8+ tumor-infiltrating lymphocytes. | Sci Adv | 2021 | 33523913 | PubTator, text mining | PubMed |
| Genetic and molecular biology of systemic lupus erythematosus among Iranian patients: an overview. | Auto Immun Highlights | 2021 | 33516274 | PubTator, text mining | PubMed |
| Integrated Analysis of Methylomic and Transcriptomic Data to Identify Potential Diagnostic Biomarkers for Major Depressive Disorder. | Genes (Basel) | 2021 | 33513891 | PubTator, text mining | PubMed |
| Biomarker Discovery in Patients with Immunotherapy-Treated Melanoma with Imaging Mass Cytometry. | Clin Cancer Res | 2021 | 33504554 | PubTator, text mining | PubMed |
| The Role and Therapeutic Targeting of JAK/STAT Signaling in Glioblastoma. | Cancers (Basel) | 2021 | 33498872 | PubTator, text mining | PubMed |
| Enrichment of branched chain amino acid transaminase 1 correlates with multiple biological processes and contributes to poor survival of IDH1 wild-type gliomas. | Aging (Albany NY) | 2021 | 33493139 | PubTator, text mining | PubMed |
| Diagnostic performances of leucine-rich α-2-glycoprotein 1 and stem cell factor for diagnosis and follow-up of colorectal cancer. | J Genet Eng Biotechnol | 2021 | 33492603 | PubTator, text mining | PubMed |
| Targeting the ubiquitination/deubiquitination process to regulate immune checkpoint pathways. | Signal Transduct Target Ther | 2021 | 33479196 | PubTator, text mining | PubMed |
| Comparative analysis of drug response and gene profiling of HER2-targeted tyrosine kinase inhibitors. | Br J Cancer | 2021 | 33473169 | PubTator, text mining | PubMed |
| A High-Dimensional Window into the Micro-Environment of Triple Negative Breast Cancer. | Cancers (Basel) | 2021 | 33467084 | PubTator, text mining | PubMed |
| Therapeutic Approaches for Metastases from Colorectal Cancer and Pancreatic Ductal Carcinoma. | Pharmaceutics | 2021 | 33466892 | PubTator, text mining | PubMed |
| Overcoming Challenges for CD3-Bispecific Antibody Therapy in Solid Tumors. | Cancers (Basel) | 2021 | 33466732 | PubTator, text mining | PubMed |
| CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis. | Signal Transduct Target Ther | 2021 | 33431788 | PubTator, text mining | PubMed |
| The Functional Crosstalk between Myeloid-Derived Suppressor Cells and Regulatory T Cells within the Immunosuppressive Tumor Microenvironment. | Cancers (Basel) | 2021 | 33430105 | PubTator, text mining | PubMed |
| The clinical significance of HERV-H LTR -associating 2 expression in cervical adenocarcinoma. | Medicine (Baltimore) | 2021 | 33429737 | PubTator, text mining | PubMed |
| B7-H4 induces epithelial-mesenchymal transition and promotes colorectal cancer stemness. | Pathol Res Pract | 2021 | 33429327 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79679/papers?page=65